ARTICLE | Distillery Therapeutics
Cancer
September 26, 2017 7:58 PM UTC
In vitro, cell culture and mouse studies identified a biguanide-based CYP3A4 inhibitor that could help treat breast cancer. Chemical synthesis and in vitro assays on biguanide analogs identified a com...
BCIQ Target Profiles